Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopy is superior to CT for tumor staging in Barrett's

In suspected early cancer in Barrett's, endoscopic ultrasound is superior to computed tomography for tumor node staging, finds October's American Journal of Gastroenterology.

News image

fiogf49gjkf04

Computed tomography(CT) and endoscopic ultrasound are part of the regular staging protocol in esophageal cancer.

The value of the 2 methods was assessed in patients with early cancer in Barrett's esophagus.

Dr Oliver Pech and colleagues from Germany evaluated 100 consecutive patients with a median age of 64 years.

The investigators assigned patients with suspected early cancer in Barrett's to a standardized staging program with upper gastrointestinal endoscopy.

Endoscopic ultrasound, computed tomography of the chest and upper abdomen, and abdominal ultrasonography were performed.

The investigators summarized the results in accordance with the tumor node metastases classification.

Sensitivity of endoscopic ultrasound for N staging was 75%
American Journal of Gastroenterology

On the basis of the lymph node findings on computed tomography and/or endoscopic ultrasound, the patients were assigned to 3 categories.

Patients in category 1 had no suspicious lymph nodes.

The investigators assigned patients with paraesophageal lymph nodes less than 1 cm in size at the tumor level to category 2.

These patients also had lymph nodes more than 1 cm in size not at the tumor level in the mediastinum or celiac trunk.

In category 3, the team included patients with paraesophageal lymph nodes more than 1 cm in size at the tumor level.

The endoscopic ultrasound and computed tomography findings were checked every 6 months in patients who underwent endoscopic treatment.

The investigative team scheduled surgical resection in operable patients if staging showed a T category higher than T1.

The team also undertook surgical resection in patients where the lymph node staging was assessed according to the classification of category 3.

Patients with suspected submucosal infiltration underwent diagnostic endoscopic resection.

If submucosal involvement was confirmed, the patients were referred for surgery.

The investigators reported that the median follow-up period was 25 months.

The T category diagnosed with computed tomography was T1 or less in all patients.

On endoscopic ultrasound, the T category was classified as T1 in 92% of cases, and as more than T1 in 8%.

The investigators detected enlarged lymph nodes in 45% of the patients.

The investigative team diagnosed significantly more category 2 lymph nodes with endoscopic ultrasound than computed tomography.

The team identified lymph nodes at the level with the highest suspicion, in category 3, using computed tomography in only 3 of 9 cases.

Sensitivity of computed tomography for N staging was 38% compared with 75% for endoscopic ultrasound.

The investigators found no extranodal metastases on computed tomography.

Dr Pech's team concludes, “In suspected early cancer in Barrett's esophagus, endoscopic ultrasound is superior to computed tomography for T staging and N staging.”

“Computed tomography had no influence on the tumor node metastases classification in any of these patients.”

“It may therefore be possible to dispense with this method as a staging procedure in patients with cancer in Barrett's esophagus.”

“By contrast, endoscopic ultrasound is required in order to differentiate between patients with cancer in Barrett's esophagus in whom endoscopic therapy is suitable and those in whom surgical treatment is required.”

Am J Gastroenterol 2006: 101(10): 2223
13 October 2006

Go to top of page Email this page Email this page to a colleague

 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 20 December 2017 
Management of abnormal liver blood tests
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us